NCT00956254View on ClinicalTrials.gov

Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
MucositisPainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

Fentanyl sublingual spray

Fentanyl was supplied in single-dose glass vials assembled into a delivery device to be used as a sublingual spray.

Trial Locations (1)

85258

InSys Therapeutics, Incorporated, Scottsdale

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY